Symposia program
- A New Dawn of Treatment for Anemia in CKD
- Organized by Zydus Lifesciences
- Friday 23 September – 12:45 – 13:45
- Moderators: Vivekanand Jha, Dibya Singh Shah
-
Title Speaker The global burden of anemia in CKD N. Gopalakrishnan The unmet treatment need in CKD anemia Manisha Sahay A responsible use of HIF-PHIs – a new addition to the treatment arsenal Dinesh Khullar Panel discussion Vijay Kher
Narayan Prasad
Umesh Khanna
Tarun Jeloka
Chula Herath
Urmila Anandh
- Extracorporeal Hemoadsorption in Critically Ill Patients
- Organized by Biocon Biologics
- Moderator: Vijay Kher
- Saturday 24 September – 7:30 – 8:15
-
Time Title Speaker Extracorporeal hemoadsorption in critically ill patients Rajib Paul The importance of the right patient selection, timing and dosing Rajib Paul Panel discussion Sanjiv Jasuja
Rajib Paul
AVSSN Sridhar
Vinant Bharghava
- Finerenone: A New Hope for Improved Cardiorenal Outcomes in Patients with CKD in T2D
- Organized by Bayer
- Saturday 24 September – 12:45 – 13:45
- Moderator: Vivekanand Jha
-
Title Speaker CKD in T2D: How urgently do we heed the call for treatment? Sanjeev Gulati Cardiorenal protection in patients with CKD and T2D: From FIDELIO-DKD to FIDELITY Dinesh Khullar Practical use of Finerenone: Whom to treat, when and how? Alan Almeida Panel discussion Vivekanand Jha
Dinesh Khullar
Sanjeev Gulati
Alan Almeida
- Protecting the Kidneys from COVID-19 Infection and Reducing Renal Risk Across the Spectrum – From Pre to Post Renal Replacement
- Organized by AstraZeneca
- Sunday 25 September – 12:45 – 13:45
-
Title Speaker Novel therapies for CKD – Targeting the different drivers of kidney disease Vijay Kher Panel discussion on How to use SGLT2 inhibitors in clinical practice for CKD Moderator: Prem Prakash Varma
Vijay Kher
Anil Kumar Bhalla
Sanjeev Gulati
Urmila Anandh
Impact of COVID on CKD management and emerging Monoclonal Antibodies for prophylaxis of high risk patients Chair: Vijay Kher
Dorry Segev
Industry exhibitors
